The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Acadia Pharmaceuticals Inc’s current trading price is -53.35% away from its 52-week high, while its distance from the 52-week low is -1.89%. The stock’s price range for this period has been between $16.16 and $33.99 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.12 million for the day, a number notably higher than the average daily volume of 1.84 million over the last three months.
Acadia Pharmaceuticals Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $33.99 on 07/18/23, while the lowest price for the same duration was marked at $16.16 on 05/09/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Acadia Pharmaceuticals Inc (ACAD) has experienced a quarterly decline of -38.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.62B and boasts a workforce of 598 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 23.14, with a change in price of -12.24. Similarly, Acadia Pharmaceuticals Inc recorded 1,762,413 in trading volume during the last 100 days, posting a change of -43.62%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ACAD stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.11.
ACAD Stock Stochastic Average
As of today, Acadia Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 4.76%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 19.50%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 45.96% and 49.13%, respectively.
ACAD Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -49.36% this year. Over the last six months, there has been a stronger performance of -32.53%. The price of ACAD leaped by -10.58% during the last 30 days period. For the last 5-days stocks have slided -7.17%.
